For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Poniard Pharmaceuticals, Inc.

USPTO Granted Patents = 14

Forward Citations = 38

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Alan R Fritzberg (7 out of 53 patents)

Sudhakar Kasina (4 out of 50 patents)

David A Karlin (4 out of 5 patents)

4. Hazel B Breitz (4 out of 4 patents)

5. Paul L Weiden (4 out of 4 patents)

6. Kent R Thoelke (3 out of 6 patents)

7. James Kyle Bryan (3 out of 6 patents)

8. Mark D Hylarides (3 out of 12 patents)

9. Elizabeth K John (3 out of 6 patents)

10. Lauren Marie Tatalick (3 out of 12 patents)

11. Paul G Abrams (2 out of 19 patents)

12. David John Grainger (1 out of 42 patents)

13. John M Reno (1 out of 45 patents)

14. James C Metcalfe (1 out of 20 patents)

15. Jonathan F Tait (1 out of 10 patents)

14 patents: Sort by Forward Citations

1. 8178564 - Use of picoplatin to treat colorectal cancer (2012-05-15),

2. 8173686 - Use of picoplatin to treat colorectal cancer (2012-05-08),

3. 8168662 - Use of picoplatin to treat colorectal cancer (2012-05-01),

4. 8168661 - Use of picoplatin to treat colorectal cancer (2012-05-01),

5. 7744853 - Radiolabeled annexins (2010-06-29),

6. 7696331 - High dose radionuclide complexes for bone marrow treatment (2010-04-13),

7. 7691985 - Skeletal-targeted radiation to treat bone-associated pathologies (2010-04-06),

8. 7674886 - Bridged aromatic substituted amine ligands with donor atoms (2010-03-09),

9. 7605239 - Skeletal-targeted radiation to treat bone-associated pathologies (2009-10-20),

10. 7511070 - Compounds and therapies for the prevention of vascular and non-vascular pathologies (2009-03-31),

11. 7408046 - Treatment of bone-associated cancers (2008-08-05),

12. 7385042 - Therapeutic and diagnostic compounds, compositions, and methods (2008-06-10),

13. 7378077 - High dose radionuclide complexes for bone marrow suppression (2008-05-27),

14. 7268220 - Bridged aromatic substituted amine ligands with donor atoms (2007-09-11),

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative oncology products. They focus on advancing novel therapies for the treatment of cancer patients. With their expertise in oncology, Poniard Pharmaceuticals aims to provide improved treatment options, ultimately enhancing the lives of those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#124 in Seattle, WA

#455 in Washington

#21,640 in US

#40,937 in the World

Seattle, WA, United States of America

Poniard Pharmaceuticals, Inc.

Forward Citations = 38

15 inventors:

Alan R Fritzberg (7 out of 53 patents)

Sudhakar Kasina (4 out of 50 patents)

David A Karlin (4 out of 5 patents)

4. Hazel B Breitz (4 out of 4 patents)

5. Paul L Weiden (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…